No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost Publication No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost Quantitative systems pharmacology (QSP) models generate predictions by formalizing biological understanding and integrating multiscale data,…CertaraNovember 16, 2023
The “Animal Rule” – What if a clinical trial simply isn’t ethical? Blog The “Animal Rule” – What if a clinical trial simply isn’t ethical? Clinical trials always pose a challenge to demonstrating a drug’s safety and efficacy. Sometimes, the…CertaraNovember 10, 2023
Certara Reports Third Quarter 2023 Financial Results Press Release Certara Reports Third Quarter 2023 Financial Results Reiterates Full Year 2023 Financial Guidance PRINCETON, N.J.— November 8, 2023-- Certara, Inc. (Nasdaq: CERT), a…CertaraNovember 8, 2023
Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval? On-Demand Webinar Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval? Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…CertaraNovember 7, 2023
Strategy to overcome clinical pharmacology challenges for regulatory approvals [APAC Webinar] On-Demand Webinar Strategy to overcome clinical pharmacology challenges for regulatory approvals [APAC Webinar] Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…CertaraNovember 6, 2023
Why Are Medicinal Chemists Reluctant to Use AI/ML Tools? Blog Why Are Medicinal Chemists Reluctant to Use AI/ML Tools? There is a lot of current chatter about how AI/ML tools like ChatGPT will soon…CertaraNovember 2, 2023
Overcoming Medicinal Chemists’ Reluctance to Use AI/ML Tools Blog Overcoming Medicinal Chemists’ Reluctance to Use AI/ML Tools AI/ML tools in drug discovery, concerns about data quality and availability, interpretability of decision-making, and…CertaraNovember 2, 2023
Certara Recognized as 2023 Employer of Choice Announcement Certara Recognized as 2023 Employer of Choice PRINCETON, N.J.— November 1 2023, Certara (Nasdaq: CERT), a global leader in biosimulation, today announced…CertaraNovember 1, 2023
Using QSP Modeling to Advance Knowledge and Therapeutics for Alzheimer’s and Parkinson’s Disease Press Coverage Using QSP Modeling to Advance Knowledge and Therapeutics for Alzheimer’s and Parkinson’s Disease CertaraOctober 30, 2023
Can’t ChatGPT Do That? Practical Applications for AI in Drug Development On-Demand Webinar Can’t ChatGPT Do That? Practical Applications for AI in Drug Development Deployed strategically, AI tools can revolutionize how organizations utilize data to discover insights that enhance…CertaraOctober 30, 2023